Safety, Tolerability, and Pharmacokinetics of Fidaxomicin in Pediatric Subjects With Clostridium Difficile-associated Diarrhea (CDAD)

Inclusion Criteria:

- Male or female 6 months to 17 years 11 months of age, inclusive;

- Female subjects of childbearing potential must use adequate contraception

- Diagnosed with CDAD

Exclusion Criteria:

- Concurrent use of oral vancomycin or metronidazole or any other effective treatments
for CDAD

- Fulminant colitis

- History of inflammatory bowel disease

- Pregnant or breast-feeding

- Need for concurrent use of some P-glycoprotein inhibitors during therapy